Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06066502 · ClinicalTrials.gov registry record · Phase 3

Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

A Phase 3 study of Respiratory Failure and Acute Respiratory Distress Syndrome, sponsored by Beth Israel Deaconess Medical Center.

Recruiting
Registry status
Phase 3
Development phase
1,100
Enrollment target
20
Study locations

NCT06066502: Recruiting Phase 3 study of Respiratory Failure and Acute Respiratory Distress Syndrome, sponsored by Beth Israel Deaconess Medical Center.

NCT06066502 is a Phase 3 study of Respiratory Failure and Acute Respiratory Distress Syndrome that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 1,100 participants, below the 4,496-participant average among 40 other Respiratory Failure trials with a reported enrollment target (76% lower). The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06066502, a Phase 3 study of Respiratory Failure and Acute Respiratory Distress Syndrome, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.

RECRUITING
Registry status
Phase 3
Development phase
1,100 participants
Enrollment target
20
Study locations

Study Summary

The goal of this interventional study is to compare standard mechanical ventilation to a lung-stress oriented ventilation strategy in patients with Acute Respiratory Distress Syndrome (ARDS). Participants will be ventilated according to one of two different strategies. The main question the study hopes to answer is whether the personalized ventilation strategy helps improve survival.

Primary Outcome

All-cause, all-location mortality

Interventions

  • OTHER Precision ventilation
  • OTHER Guided usual care ventilation

Study Locations (20)

California

  • University of California, San Diego - La Jolla
  • University of California, Los Angeles Medical Center - Los Angeles
  • Cedar-Sinai Medical Center - Los Angeles
  • University of California, San Francisco - San Franciso

Massachusetts

  • Tufts Medical Center - Boston
  • Massachusetts General Hospital - Boston
  • Brigham and Women's Hospital - Boston
  • Beth Israel Deaconess Medical Center - Boston

New York

  • NYU Lagone Health - New York
  • New York City Health + Hospitals/ Bellevue - New York
  • Albert Einstein College of Medicine/Montefiore Medical Center - The Bronx

Ohio

  • University of Cincinnati - Cincinnati
  • Cleveland Clinic Foundation - Cleveland
  • Ohio State University Wexner Medical Center - Columbus

North Carolina

  • Duke University Medical Center - Durham
  • Atrium Health Wake Forest Baptist - Winston-Salem

Arizona

  • University of Arizona - Tucson

Illinois

  • University of Chicago - Chicago

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 1,100 participants
Start Date 2024-06-24
Est. Completion 2030-08-31
Phase Phase 3

What NCT06066502 shows while recruiting

NCT06066502 is an interventional study that assigns participants to a tested intervention. Its 1,100 participants enrollment target places it among the larger protocols in the corpus, below the 4,496-participant average among 40 other Respiratory Failure trials with a reported enrollment target (76% lower).

The record links to 2 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Precision ventilation is the first listed.

NCT06066502 names 20 study sites across 9 states, led by California, Massachusetts, New York.

Frequently Asked Questions

What is clinical trial NCT06066502 about?

NCT06066502 is a clinical study titled "Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome". The goal of this interventional study is to compare standard mechanical ventilation to a lung-stress oriented ventilation strategy in patients with Acute Respiratory Distress Syndrome (ARDS). Participants will be ventilated according to one of two different strategies. The main question the study ho...

What is the current status of trial NCT06066502?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 1,100 participants. The study started on 2024-06-24. Estimated completion is 2030-08-31.

What conditions does trial NCT06066502 study?

This clinical trial studies the following conditions: Respiratory Failure, Acute Respiratory Distress Syndrome.

What interventions are being tested in trial NCT06066502?

The interventions under investigation include: Precision ventilation (OTHER), Guided usual care ventilation (OTHER).

Who is sponsoring clinical trial NCT06066502?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06066502 being conducted?

This trial has 20 study locations across Arizona, California, Illinois, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06066502's enrollment target sits among peer trials

1,100 6th of 40 higher than 35 of 40 other Respiratory Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00710112 · 1,100 participants

    Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants

  • NCT02688517 · 1,100 participants

    Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

  • NCT04743765 · 1,100 participants · NA

    HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

  • NCT05638581 · 1,100 participants · Phase 3

    Trauma Resuscitation With Low-Titer Group O Whole Blood or Products

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06066502, the US trial registry maintained by the National Library of Medicine. NCT06066502 (large enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.